BEAT HeartBeam, Inc.
$0.42 -6.36%
Updated
Healthcare · Surgical & Medical Instruments & Apparatus
HeartBeam, Inc. (BEAT) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $24 million. Shares last traded at $0.42, 90.5% below their 52-week high. Over the past year the stock is down 69.7%.
Market Cap
$24M
Shares Out
56.3M
EPS (TTM)
$-1.13
P/E Ratio
—
P/S Ratio
—
P/B Ratio
2.92
Dividend / Share
—
Dividend Yield
—
52-Week High
$4.45
52-Week Low
$0.42
Volume
3,233
Avg Vol (3m)
11,983.19
Performance
1W
-13.02%
1M
-14.20%
3M
-53.22%
6M
-69.74%
YTD
-82.64%
1Y
-69.74%
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
RSI (14)
31.18
SMA (50)
$0.55
SMA (200)
$1.16
Price vs SMA50
-23.28%
Price vs SMA200
-63.36%
ATR (14)
$0.03
Financials
Revenue
—
Net Income
$-20M
Gross Margin
—
Operating Margin
—
Net Margin
—
Return on Equity
-248.2%
Return on Assets
-190.8%
Current Ratio
3.66
Debt / Equity
0.30
Revenue Growth (YoY)
—
Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $-0.21 | 2026-08-13 |
| Q1 2026 | $-0.12 | 2026-05-13 |
| FY 2025 | $-0.62 | 2026-03-12 |
| Q3 2025 | $-0.48 | 2025-11-13 |
| Q2 2026 | $-0.32 | 2026-08-13 |
| Q1 2026 | $-0.18 | 2026-05-13 |
Surgical & Medical Instruments & Apparatus peers
BEAT vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated
1–14 of 14
| SYK | Stryker Corporation | $118.2B | 31.69 | 4.57 | 14.4% | -1.31% |
| MMM | 3M | $86.8B | 28.97 | 3.45 | 11.9% | -0.28% |
| BSX | Boston Scientific | $68.0B | 18.54 | 3.24 | 17.5% | -3.17% |
| BDX | Becton Dickinson | $51.1B | 54.30 | 2.45 | 4.5% | +0.00% |
| DXCM | DexCom | $33.9B | 33.86 | 6.81 | 20.1% | +0.02% |
| RMD | ResMed | $33.1B | 21.70 | 5.85 | 26.9% | -0.78% |
| MDLN | Medline Inc. | $30.7B | — | 1.08 | — | +0.88% |
| WST | West Pharmaceutical Services | $24.1B | 42.67 | 7.25 | 17.0% | +0.00% |
| SOLV | Solventum | $15.7B | 10.97 | 1.89 | 17.3% | +0.56% |
| BAX | Baxter International | $13.2B | -12.44 | 1.15 | -9.3% | -0.51% |
| PEN | Penumbra Inc | $12.7B | 78.81 | 9.02 | 11.4% | -0.46% |
| GKOS | Glaukos Corp | $10.6B | -56.59 | 17.36 | -30.7% | +0.52% |
| GMED | Globus Medical Inc | $10.5B | 19.59 | 3.34 | 17.0% | -3.14% |
| PODD | Insulet Corporation | $10.4B | 27.82 | 3.42 | 12.3% | +1.63% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.